Gilead Sciences

Ebit Endring Dato
AbbVie USD 4.52B 378M 2023-09
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
ALKERMES USD 49.85M 189.34M 2023-09
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.8B 254M 2023-12
Eli Lilly USD 3.08B 347.4M 2023-12
Gilead Sciences USD 2.15B 475M 2023-12
GlaxoSmithKline GBP 2.59B 602M 2023-09
Incyte USD 205.23M 10.1M 2023-12
Moderna USD 6M 2.02B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -125000000 2.34B 2023-12
PTC Therapeutics USD 8.02M 126.18M 2023-12
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Sarepta Therapeutics USD -20842000 112.68M 2023-09
United Therapeutics USD 263.7M 63.3M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Gilead Sciences - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.